3.0
Oct 15, 2024
Former employee, more than 1 year
Recommend
CEO approval
Business Outlook
Pros
Very innovative platform, a lot of motivated scientists, passionate about the science
Cons
a lot of office politics, even though we're all one company, teams were very territorial about projects/programs, and often forget about the end goal of trying to accomplish a viable cell therapy product. Clear favoritism by upper management with people with PhDs and people without PhDs.